Patients with distinct myCAFs levels exhibited diverse tumor microenvironment features with altered infiltration of CD8 T cells and the polarization of M2 macrophages, further bringing differences in patients’ prognosis and treatment responses. The gene discussed is CD8A; the disease is neoplasm.